The g-chain (gc) is a transducing element shared between several cytokine receptors whose alteration causes X-linked severe combined immunodeficiency. Recently, a direct involvement of gc in selfsufficient growth in a concentration-dependent manner was described, implying a direct relationship between the amount of the molecule and its role in cell cycle progression. In this study, we evaluate whether gc expression could interfere in cell cycle progression also in malignant hematopoietic cells. Here, we first report that in the absence of gc expression, lymphoblastoid B-cell lines (BCLs) die at a higher extent than control cells. This phenomenon is caspase-3 independent and is associated to a decreased expression of the antiapoptotic Bcl-2 family members. By contrast, increased expression of gc protein directly correlates with spontaneous cell growth in several malignant hematopoietic cell lines. We, also, find that the knockdown of gc protein through short interfering RNA is able to decrease the cell proliferation rate in these malignancies. Furthermore, an increased expression of all D-type cyclins is found in proliferating neoplastic cells. In addition, a direct correlation between the amount of gc and cyclins A2 and B1 expression is found. Hence, our data demonstrate that the amount of the gc is able to influence the transcription of genes involved in cell cycle progression, thus being directly involved in the regulatory control of cell proliferation of malignant hematopoietic cells.
Introduction
The common c-chain (cc) gene localized to chromosome Xq13 encodes a transmembrane protein which is a transducing element shared by the receptors for IL-2, IL-4, IL-7, IL-9, IL-15 and IL-21 (1) . Deficiency in the expression or function of the cc causes the X-linked severe combined immunodeficiency (X-SCID), characterized by the complete absence of both T and NK lymphocytes and normal B-cell number (2) . It is known that the cytokines that act through the cc are generally growth factors (3) . Upon cytokine interaction, IL-2R activates numerous downstream signaling molecules, including Janus kinases (JAK) and signal transducers and activators of transcription (STAT). In particular, STAT5, which is directly phosphorylated and activated by JAK3 (4), seems to play a major role in cell proliferation (5) (6) (7) . cc signaling cytokines promote proliferation in T-cell acute lymphoblastic leukemia (ALL), thus implying a synergistic effect of these cytokines on tumor growth (8) . It was also reported that IL2RG cooperates with LMO2 in inducing hematopoietic tumors in X-SCID patients enrolled in gene therapy trials (9, 10) .
Recently, we documented a direct relationship between the amount of cc expression and its role in cell cycle progression. In particular, using lymphoblastoid B-cell lines (BCLs), we described a direct involvement of cc in self-sufficient growth in a concentration-dependent manner. Furthermore, the cc amount correlated with the amount of constitutively activated JAK3, while a reduction of cc protein expression resulted in reduced STAT5 nuclear translocation in BCLs (11) . This finding led to hypothesize that cc, through the modulation of genes related to growth signaling and cell cycle control, under certain circumstances plays a role as potential oncogene in tumor growth. However, whether cc is implicated in anti-apoptotic mechanism or directly involved in promoting cell signaling of cell cycle progression is not clear.
Cell cycle progression is a highly organized and regulated process that controls cell proliferation (12) . Cytokines that signal through receptors sharing the cc lead to transition into the cell cycle and thus proliferation (3) . The entry of cells into the cell cycle is controlled by an ordered expression/activation of cyclins (13) . IL-2R through cc appears to activate a variety of downstream signaling pathways that converge on the regulation of Bcl-2 (6), including PI3K and MAPK activation (14) and transcription of the c-myc gene (6) . In turn, c-myc cooperates with STAT5 to induce the expression of cyclin D and to promote proliferation (15) (16) (17) . It is clear that alterations in Bcl-2 levels exert potent effects on cellular survival and, namely, Bcl-2 overexpression can be tumorigenic (18) . Moreover, cc is required for a wide range of signaling inputs that induce cell proliferation through cyclin D3 expression (19) .
To define whether the effect of cc on cell cycle progression is a peculiarity of lymphoblastoid cells or a more general phenomenon involved in cell growth of malignancies of hematopoietic cell lineages, in this study, we evaluated whether cc expression could interfere in cell cycle progression in neoplastic cells. We also investigated whether the effect of cc is mediated by A2, B1, D1, D2 and D3 cyclins and is required for a proper activation of these cyclins in cell cycle progression.
Methods

Cell cultures
PBMCs were obtained from X-SCID patients and healthy donors by Ficoll-Hypaque (Biochrom, Berlin, Germany) density gradient centrifugation (20) . Lymphoblastoid B-cell lines (BCLs) were generated by EBV immortalization of patients and healthy donors PBMC using standard procedures. The human T-ALL cell line (Molt-4), the chronic myelogenous leukemia cell line (K-562), Burkitt lymphoma cell line and its isogenic derivatives (Raji and Rj225) were grown in RPMI-1640 (Lonza, Verviers, Belgium) supplemented with 10% fetal bovine serum (FBS; Gibco, Carlsbad, California), 2 mmol L À1 L-glutamine (Gibco), and 50 lg ml À1 gentamycine (Gibco) and cultured at 37°C, 5% CO2. Serum starvation was used to synchronize tumor cells in the G0/G1-phase of the cell cycle. The cells were incubated in medium without FBS for 24 h. In self-sufficient growth experiments, cells were cultured in DMEM/F12 (Lonza) without FBS and supplemented with 2 mmol L À1 L-glutamine.
Primary leukemic cell lines, consisting of ALL cells, were obtained from aspirated bone marrow of three patients. Normal bone marrow cells were obtained from healthy donors and used as control cells.
Cell proliferation assays and cell survival
Cells were plated in triplicate at 1 3 10 5 viable cells/well in 96-well plates (BD Biosciences, San Jose, CA), in 200 ll of complete medium for 4 days. Cultures were pulsed with 0.5 lCi 3 H-thymidine for 8 h before harvesting and the incorporated radioactivity measured by scintillation counting. Cell proliferation was also analyzed by the CFSE dilution assay. Cells (1 3 10 6 ) were resuspended in 1 ml PBS-10% FBS and labeled with 1.7 lM CFSE (Molecular Probes, Leiden, Netherlands). After 2 min in the dark at room temperature, cells were washed in FBS and PBS. After 6 h, cells were analyzed on a FACSCalibur flow cytometer using CellQuest software (BD Biosciences).
Cell viability was determined using trypan blue staining. Cell survival was evaluated following stimulation with antiFas mAb (400 ng ml
À1
; Upstate, Lake Plasid, NY) for 6 h.
Western blot analysis
Stimulated or unstimulated cells were washed with ice-cold PBS (Cambrex, Charles City, IA) and lysed in 100 ll of lysis solution containing 20 mM Tris (pH 8), 137 mM NaCl, 1% Nonidet P-40, 10 mM EDTA, 1 mM phenylmethylsulfonylfluoride, 1 mM sodium orthovanadatum (Na3VO4), 5 lg ml À1 leupeptin and 5 lg ml À1 aprotinin on ice for 45 min. The cell lysates were stored at À80°C until processing. Proteins were separated on 12% SDS-PAGE. The membranes were then washed three times in wash buffer and incubated overnight at 4°C with the specific primary Abs for IL-2Rc (Santa Cruz, Santa Cruz, CA), caspase-3 (Cell Signaling, Danvers, MA), Bcl-2, Bcl-XL and beta-actin (Santa Cruz). Immune complexes were detected using the appropriate anti-rabbit or anti-mouse peroxidase-linked Abs. ECL kit (Amersham Biosciences, Brussels, Belgium) was used for visualization.
Densitometric analysis was performed after background equalization through the ImageJ software.
siRNAs and transfection
The validated chemically modified oligonucleotides used as short interfering RNA (siRNA) for IL2RG or random nonsilencing nucleotides with no known specificity siRNA, used as negative control, were obtained from Invitrogen (Paisley, UK). These siRNAs were transfected at a concentration of 200 pmol/1 3 10 6 cells in a six well plate for 96 h. The transfection was performed by the lipid vector Lipofectamine 2000 kit (Invitrogen), according to the manufacturer's instructions. Preliminary experiments were performed to establish the silencing efficiency by testing two different oligonucleotides obtained from Invitrogen. The amount of protein expression reduction was calculated as follows: 1 À (OD siRNA 3 100/ OD control siRNA ).
Real-time quantitative reverse transcriptase PCR analysis
Total RNAs were extracted using TRIzol reagent (Invitrogen) in accordance with the manufacturer's instructions. RNA was reverse transcribed in the presence of SuperScript II RT (Invitrogen) and oligo(dT) primers (Invitrogen) at 50°C for 50 min and then at 85°C for 5 min to inactivate the enzymes. Amplification of the cDNAs was performed using the SYBR Green and analyzed with the Light Cycler480 (Roche, Branchburg, NY). Primers are listed in Table 1 . The PCR conditions comprised an initial denaturation at 94°C for 5 min, followed by 35 cycles at 62°C for 20 s and 72°C for 5 min. A dissociation procedure was performed to generate a melting curve for confirmation of amplification specificity. The results were normalized to beta-actin. The relative levels of gene expression are represented as ÀDCt = (Ct gene À Ct reference ) and the fold change in gene expression was calculated by the 2
ÀDDCt method (where Ct is cycle threshold), as previously described (21) .
Statistical analysis
MedCalc for Windows was used to analyze the data. The correlations between thymidine incorporation and cc expression and between cyclins and cc expression were obtained using the Pearson's correlation. P < 0.05 values were considered statistically significant.
Results
Deficiency in the expression of cc impairs cell survival cc-dependent cytokines have important functions related to cellular survival (3). To determine whether cc deficiency had an effect on cell survival, we examined BCLs from healthy donors and X-SCID patients. The percentage of live cells was determined using trypan blue staining in the absence or presence of anti-Fas to trigger programmed cell death (22) . In unstimulated X-SCID BCLs, there was an increase in the percentage of cell death, accounting for 25% as compared with 7% of control BCLs. Following 6 h of stimulation with anti-Fas, control and X-SCID BCLs showed a higher and comparable degree of cell death (32 and 36%) (Fig. 1A) . Data on BCLs viability was confirmed by PI staining (data not shown). The increase of cell death observed is directly related to the lack of cc expression, since the neutralization of cc-dependent cytokines, as IL-2 or IL-4, did not modify the effect of cc on cell viability of normal cells (data not shown).
Programmed cell death is mainly mediated by activation of several caspases (23) . These molecules exist as proforms that are activated by cleavage by the upstream caspase in the cascade (23) . Western blot analysis with antibodies to the cleaved/activated form of caspase-3 revealed the presence of the cleaved protein only following anti-Fas stimulation (Fig. 1B) , thus indicating that in unstimulated X-SCID BCLs the low viability was not a caspase-dependent process. Caspase-independent cell death has been attributed to mitochondrial damage (24) , which can be regulated by Bcl-2 family members (25, 26) . Bcl-2 and Bcl-XL operate as critical components in a complex network to integrate information and make ultimate life/death decisions (27) . Since the cc-dependent cytokines promote cell survival by upregulating the antiapoptotic factor Bcl-2 (28) and Bcl-XL (29), the expression of Bcl-2 and Bcl-XL in control and X-SCID BCLs was evaluated. In cc-deficient cells, the expression of Bcl-2 and Bcl-XL was greatly decreased as compared with the control (Fig. 1B) . These findings indicate that cc is required for cell survival and is dispensable for Fas-induced cell death. Moreover, the evaluation of molecular expression of Bcl-XL in unstimulated cells, through quantitative real-time PCR, revealed that in the X-SCID cells Bcl-XL mRNA was 35% of the control (Fig. 1C) .
Correlation between cc expression and cell proliferation in malignant hematopoietic cell lines
Our previous studies demonstrated that cc exerts a role in cell cycle progression on BCLs in a concentration-dependent manner (11) . To explore the potential oncogenic role of cc, we first examined the expression of the molecule in cell lines obtained from hematopoietic tumors, such as Molt-4, Raji, Rj225 and K-562. Synchronization of tumor cells in the G0/ G1-phase of the cell cycle was accomplished by 12 h serum starvation. Western blot analysis revealed different cc expression levels among these cell lines. The protein was expressed predominantly in the K-562 and to a lesser extent in the Molt-4, Raji and Rj225 in a decreasing order. In X-SCID BCLs, cc expression was completely undetectable (Fig. 2A) . Densitometric analysis is shown in the histogram in Fig. 2(B) . The expression of cc was also evaluated in primary leukemic cell lines from three patients with ALL through quantitative realtime PCR. IL-2Rc mRNA levels were increased in leukemic cells as compared with the control (Fig. 2C) .
Moreover, to determine whether the expression levels of cc correlated with the self-sufficient growth in malignant cell lines, we examined the proliferation activity of cells under serum-deficient conditions. This was first evaluated by comparing the CFSE dilution profile, upon trypan blue exclusion Bcl-XL  5#-GTAAACTGGGGTCGCATTGT-3#  5#-TGCTGCATTGTTCCCATAGA-3#  Cyclin D1  5#-AGGTCTGCGAGGAACAGAAGTG-3#  5#-TGCAGGCGGCTCTTTTTC-3#  Cyclin D2 5#-CTGTGTGCCACCGACTTTAAGTT-3# 5#-GATGGCTGCTCCCACACTTC-3# Cyclin D3
5#-GCAGCGCCTTTCCCAACT-3# 5#-TCAAAAGGAATGCTGGTGTATGTATC-3# Cyclin A2
5#-CTGCTGCTATGCTGTTAGCC-3# 5#-TGTTGGAGCAGCTAAGTCAAAA-3# Cyclin B1
5#-CGGGAAGTCACTGGAAACAT-3# 5#-AAACATGGCAGTGACACCAA-3' IL-2Rc 5#-TGCTAAAACTGCAGAATCTGGT-3# 5#-AGCTGGGATTCACTCAGGTTTG-3# Beta-actin 5#-GACAGGATGCAGAAGGAGAT-3# 5#-GACAGGATGCAGAAGGAGAT-3# assay, of malignant cells. After 5 h of serum-free culture, some variations in the rate of proliferation among the lines were already evident. As shown in Fig. 3(A and B) , 20.19% of K-562 retained the dye, indicating a high proliferation rate, compared with 40.65% of Molt-4, 45.2% of Raji and 58.64% of Rj225. No proliferation was observed in X-SCID BCLs ( Fig. 3A and B) . CFSE experiments, at longer time points, were also performed in order to exclude a delayed entry into the cell cycle in the absence of cc. We found that longer time points were not discriminative as well, since neoplastic cells reach a plateau at 24-72 h of culture (data not shown). Moreover, the proliferation of these cell lines was also assessed by 3 H-thymidine incorporation assay after 4 days of culture. K-562 exhibited significantly higher thymidine incorporation (3851 6 576 cpm) than Molt-4 (2224 6 167 cpm), Raji (2167 6 562 cpm) and Rj225 (1534 6 115 cpm). As expected, there was no proliferation in X-SCID BCLs (Fig. 3C) . These data were in keeping with the results of CFSE experiments. A statistically significant relationship between cc expression and spontaneous cell growth was documented in the examined cell lines (R = 0.98, P < 0.05) (Fig. 3D) .
In the light of these findings, we hypothesized that the inhibition of cc expression in hematopoietic malignant cell lines might have a direct effect on proliferation of these cells. siRNA was used to knockdown the molecule in these cell lines. Efficiency and specificity of targeted siRNA sequences were confirmed by western blot analysis on total lysates and quantitative real-time PCR on mRNA. As shown in Fig. 4(A and B) , the results of western blot assay revealed that at 96 h following the transfection, cells transduced with siRNA had less cc protein than the correspondent cells transduced with the control negative siRNA. In this representative experiment, ccsilencing reduced the amount of the protein in Rj225, K-562, Molt-4 and Raji by 80, 53, 62 and 32%, respectively. In addition, a decrease of the IL-2Rc mRNA was observed in all cell lines, revealing a knockdown efficiency of ;85% in this experiment. In X-SCID cells, IL-2Rc mRNA was undetectable (Fig. 4C) . Moreover, as shown in Fig. 4(D) , cc knockdown led to a significant decrease of proliferation. In particular, ccsilencing reduced cell proliferation of Rj225 by 40%, K-562 by 58%, Molt-4 by 45% and Raji by 50%, as compared with control siRNA cells (Fig. 4D) . Taken together, these data confirm that cc plays a key role in the proliferation of these malignant cell lines.
Effect of cc on molecular mechanisms of cell cycle progression in malignant hematopoietic cell lines
To examine the mechanisms by which cc regulates cell cycle progression, we examined whether different amounts of the molecule were able to influence the transcription of genes selectively involved in cell cycle. Of note, cyclins are the key regulators of cell cycle progression (13) . In particular, during the G0 to G1 phase transition, cyclins D1, D2 and D3 are the first molecules to be induced. Cyclin A2 gets activated during the transition from G1 to S phase and B type cyclins are detected during G2 exit and mitosis phase (30) . In several kinds of malignant tumors, cyclins are overexpressed (31) . Therefore, in all the above described cell lines, quantitative real-time analysis was performed to examine the effect of cc on the expression of cyclin A2, B1, D1, D2, D3 genes. As shown in Fig. 5(A) , K-562 exhibited an up-regulation of D-type cyclins to a similar extent of Molt-4, while these genes were not expressed in Raji and X-SCID BCLs. In Rj225, only the cyclin D3 mRNA was up-regulated. Interestingly, we found that cyclins A2 and B1 were undetectable in X-SCID BCLs and reached a maximal expression in K-562 (Fig. 5B) . In Molt-4, Rj225 and Raji, the levels of the cyclins A2 and B1 were lower than in K-562 (Fig. 5B) . A direct correlation between cyclins A2 and B1 and cc expression was found (P < 0.05) (Fig. 5C and D) . These data are consistent with the direct correlation previously shown between functional and molecular data of cc amount.
Discussion
Our results first indicate that in the absence of cc expression, BCLs die at a higher extent than control cells. This phenomenon is not related to abnormalities of regulatory mechanisms of apoptosis, in that, in non-stimulated cells, the absence of cc does not induce an increase of the activated form of caspase-3 that represents the central executioner molecule in the development of programmed cell death process. Hallmark of non-caspase-mediated cell death is the mitochondrial damage (24) , which can be regulated by Bcl-2 family members (25) . The cc-dependent cytokines promote cell survival by up-regulating the antiapoptotic Bcl-2 and Bcl-XL factors. In keeping with this, we found a decreased expression of Bcl-2 and Bcl-XL in cc-deficient cells. Of note, this effect was related to the lack of cc per se and not a secondary effect of unfunctional cc-dependent cytokines IL-2 or IL-4, in that neutralization of these cytokines did not modify cell viability of normal cells. As for the mechanism of non-caspase-mediated apoptosis, there is evidence indicating that autophagy may play an active role in cell death under unfavorable settings, such as nutrient or growth factors deprivation (27) . However, whether cc is implicated in the autophagy process still needs to be addressed.
In spite of a wide number of studies on the molecular interactions and functions of cc, the precise role of this molecule in cell biology is still far from being clear. It has recently been documented a direct relationship between the amount of cc expression and the proliferative capability of control lymphoblastoid cells (11) , implying a direct involvement of cc in self-sufficient growth in a concentration-dependent manner. Moreover, it was previously reported that IL2RG cooperates with LMO2 in inducing hematopoietic tumors by studies of insertional mutagenesis in mice (32), thus giving a potential explanation to lymphoproliferative disorders occurring during gene therapy trials for X-SCID (9, 10) . It is noteworthy that, differently from X-SCID, no clonal lymphoproliferation has been reported, to date, in patients receiving gene therapy for ADA deficiency (33) , despite the observation of a similar frequency of integration sites near LMO2 and other proto-oncogenes (34) . Furthermore, a recent study, based on an experimental model of gene transfer in ccÀ/À mice, documented that cc overexpression could exert oncogenic properties by itself (35) .
In this study, we observed that the amount of cc protein expression in several malignant cell lines directly correlates with spontaneous cell growth. We, also, found that the knockdown of cc molecule through siRNA is able to decrease the cell proliferation rate in these malignancies, thus confirming a direct involvement of the molecule as a key player in cell cycle progression.
The cancer is a multistep process that requires mutations of multiple molecules implicated in the biochemical signaling (36) . It is known that constitutive activation of JAK3 has been observed in a spectrum of lymphoid malignancies (37) . In particular, JAK overexpression can be considered as one of the main biologic events leading to the constitutive activation of the JAK-STAT pathway that contributes to oncogenesis (38) . It has been demonstrated that the amount of constitutively activated JAK3 parallels the extent of cc expression (11) . Moreover, STAT molecules and, in particular the nearly identical STAT5 A and B (39) , have been demonstrated to directly participate in tumor development and progression. STAT5 participates in oncogenesis through up-regulation of genes encoding cell cycle regulators, such as cyclins (40) . Alterations in cell cycle machinery, mainly in the regulation of G1/S phase, are known to be associated to the development of solid tumors as well as hematological malignant diseases (31) . In this context, a direct involvement of cyclins in malignant cell growth has been well documented and a correlation between the extent of cyclins expression/activation and the rate of proliferation has been found. Namely, cyclins A2 and B1 have been implicated in the pathogenesis of cancer and are overexpressed in several tumors (41, 42) . Evidence indicates that these cyclins are key components of the cell-cycle machinery (43) and, in particular, cyclin A is expressed at high levels in hematopoietic stem cells and is essential for their proliferation (44) . In our study, we observed that the expression of A2 and B1 cyclins strongly paralleled the proliferative capability of malignant cell lines. Interestingly, a positive correlation between the amount of cc and the expression of cyclins A2 and B1 was also found. Taken together, these data indicate that the higher is the rate proliferation of a certain cell line the higher is the expression of both cc and cyclins A2 and B1, thus confirming their involvement in the process in a concentration-dependent fashion.
We also found an increased expression of all D-type cyclins in those cell lines that proliferated mostly, K-562 and Molt-4, whereas they were not expressed in the other cell lines, but D3 found in Rj225. D-type cyclins are strongly expressed in many malignancies. Overexpression of cyclin D1 protein was documented in many forms of cancer, including breast cancer (45) , while overexpression of cyclin D2 was noted in a wide range of B-cell malignancies, such as B-cell chronic lymphocytic leukemia (46) . Like the other D cyclins, cyclin D3 is rearranged and the protein is overexpressed in several human lymphoid malignancies. It was documented that knockdown of cyclin D3 inhibits the proliferation of ALL cells (47) . However, while A-and B-type cyclins seem to be vital and necessary components of cell cycle progression (44) , D-type cyclins may be dispensable for proliferation under certain circumstances, in that different cell types are sensitive to cyclin D knockdown at a different extent (48) . This would suggest that they regulate cell cycle in a cell type-specific manner and that there are alternative mechanisms allowing cell cycle progression in a cyclin D-independent fashion (48) . Anyway, a critical role for oncogenic transformation of D-type cyclins is a well-established feature.
Our data indicate that cc is strongly implicated in cell cycle progression of hematopoietic malignancies in a similar fashion to the role played in control lymphoblastoid cells, as previously shown. This biologic effect is strictly dependent on the expression level of the molecule and can be abolished by gene knockdown. Of note, a direct correlation between the amount of cc expression and the proliferative capability of the malignant cell lines and the regulatory elements of cell cycle progression, A and B cyclins, was found.
Moreover, we documented that the IL-2Rc mRNA was also highly expressed in primary leukemic cells, thus confirming a direct involvement of the cc in tumor growth. Our data could provide the basis to develop in the near future new therapeutic strategies targeting this molecule in cancer therapy. Moreover, this information may also help understand undesired side effects of gene therapy trials.
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